Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice

Clinical and Experimental Immunology

Volumn 137, Issue 2, 2004, Pages 288-297

  Gavanescu, I ^a   Pihan, G ^a   Halilovic, E ^a   Szomolanyi Tsuda, E ^a   Welsh, R M ^a   Doxsey, S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoantibodies; Autoimmunity; Centrosome; Infection; Scleroderma

Indexed keywords

AUTOANTIBODY; CIPROFLOXACIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; CENTROSOME; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; MALE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CELL LINE; CENTROSOME; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOPLASMA; MYCOPLASMA INFECTIONS; SCLERODERMA, SYSTEMIC;

EID: 3542998760     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02535.x     Document Type: Article

References (46)

1. Tan EM, Chan EK, Sullivan KF, Rubin RL. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988; 47:121-41.
2. Sontheimer RD, McCauliffe DP, Zappi E, Targoff I. Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol 1992; 7:3-52.
3. Walton KW. Hypersensitivity and infection in the pathogenesis of the rheumatic diseases. Int Rev Exp Pathol 1968; 6:285-374.
4. Cole BC, Golightly-Rowland L, Ward JR. Arthritis of mice induced by Mycoplasma arthritidis. Humoral antibody and lymphocyte responses of CBA mice. Ann Rheum Dis 1976; 35:14-22.
5. Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 1994; 24:190-210.
6. Bach JF, Koutouzov S, van Endert PM. Are there unique autoantigens triggering autoimmune diseases? Immunol Rev 1998; 164:139-55.
7. Rose NR. Infection, mimics, and autoimmune disease. J Clin Invest 2001; 107:943-4.
8. Flaegstad T, Fredriksen K, Dahl B, Traavik T, Rekvig OP. Inoculation with BK virus may break immunological tolerance to histone and DNA antigens. Proc Natl Acad Sci USA 1988; 85:8171-5.
9. Olding LB, Kingsbury DT, Oldstone MB. Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection. J Generalvirol 1976; 33:267-80.
10. Sangster MY, Topham DJ, D'Costa S et al. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 2000; 164:1820-8.
11. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283:1335-9.
12. Ray SK, Putterman C, Diamond B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci USA 1996; 93:2019-24.
13. Briles DE, Forman C, Hudak S, Claflin JL. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 1982; 156:1177-85.
14. Shaw PX, Horkko S, Chang MK et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105:1731-40.
15. Hiepe F, Dorner T, Burmester G. Antinuclear antibody- and extractable nuclear antigen-related diseases. Int Arch Allergy Immunol 2000; 123:5-9.
16. Scofield RH, Zhang FC, Kurien BT, Harley JB. Anti-Ro fine specificity defined by multiple antigenic peptides identifies components of tertiary epitopes. Clin Exp Immunol 1997; 109:480-7.
17. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001; 2:797-801.
18. Gilliland BC. Systemic sclerosis (scleroderma). Harrison's Principles of Internal Medicine. New York: The McGraw-Hill Companies, 1998.
19. Jimenez SA, Diaz A, Khalili K. Retroviruses and the pathogenesis of systemic sclerosis. Int Rev Immunol 1995; 12:159-75.
20. Lunardi C, Bason C, Navone R et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6:1183-6.
21. Kellogg DR, Moritz M, Alberts BM. The centrosome and cellular organization. Annu Rev Biochem 1994; 63:639-74.
22. Doxsey S. Re-evaluating centrosome function. Nat Rev Mol Cell Biol 2001; 2:688-98.
23. Gavanescu I, Vazquez-Abad D, McCauley J, Senecal JL, Doxsey S. Centrosome proteins: a major class of autoantigens in scleroderma. J Clin Immunol 1999; 19:166-71.
24. Doxsey SJ, Stein P, Evans L, Calarco PD, Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell 1994; 76:639-50.
25. Fauci AS. Autoantibodies to Centrosome Proteins in Scleroderma. Harrison's Principles of Internal Medicine harrisonsonline. New York: The McGraw-Hill Companies, 2001.
26. Barile MF, Razin S. The Mycoplasmas: Cell Biology. New York: Academic Press 1979.
27. Rosengarten R, Wise KS. Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science 1990; 247:315-8.
28. Craft J, Fatenejad S. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997; 40:1374-82.
29. Linnik KM, Herscovitz H. Multiple molecular chaperones interact with apolipoprotein B during its maturation. The network of endoplasmic reticulum-resident chaperones (ERp72, GRP94, calreticulin, and BiP) interacts with apolipoprotein b regardless of its lipidation state. J Biol Chem 1998; 273:21368-73.
30. Nelson DS, Alvarez C, Gao YS, Garcia-Mata R, Fialkowski E, Sztul E. The membrane transport factor TAP/p115 cycles between the Golgi and earlier secretory compartments and contains distinct domains required for its localization and function. J Cell Biol 1998; 143:319-31.
31. Auer-Grumbach P, Achleitner B. Epidemiology and clinical associations of NuMA (nuclear mitotic apparatus protein) autoantibodies. J Rheumatol 1994; 21:1779-81.
32. Cimolai N, Mah D, Roland E. Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection. J Neurol Neurosurg Psychiatry 1994; 57:638-9.
33. Gentric A, Blaschek M, Julien C et al. Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. Clin Immunol Immunopathol 1991; 59:487-94.
34. Huidbuchel E, Blaschek M, Seigneurin JM, Lamour A, Berthelot JM, Youinou P. Anti-organelle and anti-cytoskeletal autoantibodies in the serum of Epstein-Barr virus-infected patients. Ann Med Interne (Paris) 1991; 142:343-6.
35. Lind K, Hoier-Madsen M, Wiik A. Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun 1988; 56:714-5.
36. Bockenstedt LK, Gee RJ, Mamula MJ. Self-peptides in the initiation of lupus autoimmunity. J Immunol 1995; 154:3516-24.
37. Cassell GH, Gray GC, Waites KB. Mycoplasma Infections. Harrison's Principles of Internal Medicine harrisonsonline. New York: The McGraw-Hill Companies, 2001.
38. Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-25.
39. Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int J Biochem Cell Biol 2002; 34:901-6.
40. Takeuchi O, Kaufmann A, Grote K et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164:554-7.
41. Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000; 165:6635-43.
42. Conrad K, Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol 2000; 123:77-91.
43. Mack GJ, Rees J, Sandblom O, Balczon R, Fritzler MJ, Rattner JB. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome. Arthritis Rheum 1998; 41:551-8.
44. Osborn TG, Patel NJ, Ross SC, Bauer NE. Antinuclear antibody staining only centrioles in a patient with scleroderma. N Engl J Med 1982; 307:253-4.
45. Le CH, Morales A, Trentham DE. Minocycline in early diffuse scleroderma. Lancet 1998; 352:1755-6.
46. Over KE, Bucknall RC. Regression of skin changes in a patient with systemic sclerosis following treatment for bacterial overgrowth with ciprofloxacin. Br J Rheumatol 1998; 37:696.